- Home
- SUUN vs ABVC Comparison
SUUN vs ABVC Comparison
Compare SUUN & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SUUN | ABVC |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.3M | 58.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SUUN | ABVC |
|---|---|---|
| Price | $1.54 | $2.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 65.6K |
| Earning Date | 02-13-2026 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $32,753,484.00 | $797,916.00 |
| Revenue This Year | $127.67 | $735.18 |
| Revenue Next Year | $4.98 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 56.52 |
| 52 Week Low | $1.23 | $0.40 |
| 52 Week High | $6.43 | $5.48 |
Technical Indicators
Market Signals| Indicator | SUUN | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 45.99 | 40.22 |
| Support Level | $1.45 | $1.98 |
| Resistance Level | $1.75 | $2.20 |
| Average True Range (ATR) | 0.17 | 0.15 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 16.03 | 14.89 |
Price Performance
Historical ComparisonAbout SUUN SolarBank Corporation
PowerBank Corp is an independent renewable and clean energy project developer, power producer, and asset operator in Canada and the United States, with the majority of its revenue coming from the United States. The Company operates through two reportable segments: Development and EPC, which involves the development and construction of solar photovoltaic power projects, and IPP Production, which includes the operation of solar power and battery energy storage systems. Corporate and other activities cover operation, maintenance, and repairs. The majority of revenue is generated from the Development and EPC segment.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.